Federal- and state-level attention drove technology adoption
Prescriptions routed electronically more than doubled to 68 million in 2008, rising from 29 million in 2007. And the increased participation by payers in e-prescribing enabled access to prescription benefit and history information for 65% of patients in the U.S, according to the newly released 2008 National Progress Report on E-Prescribing from health information network provider SureScripts (Alexandria, VA).
One factor that influenced the growth of e-prescribing, the company says, was attention at the federal and state policy level. National programs drove e-prescribing and provided tools for use by such key players as payers (pharmacy benefit management and Medicaid plans) and pharmacies. Doctors receive an incentive for e-prescribing for Medicare patients. Each player benefits in its own way from e-prescribing, accelerating adoption of the technology.
The result: more than 100,000 prescribers are now routing prescriptions electronically in the U.S, says SureScripts. And the use of three critical components of e-prescribing—electronic prescription benefit, history, and routing—jumped 61% in the first quarter of 2009, resulting in more than 134 million e-prescribing messages being exchanged among prescribers, payers, and pharmacies.
Among other report findings:
Healthcare IT provider Allscripts (Chicago) announced separately that it had routed more electronic prescriptions over the SureScripts network than any other e-prescribing or electronic health record solution provider.
“Electronic prescribing is an easy first step for physicians to move towards an electronic health record, and a logical place to start because of the huge cost—in dollars and human lives—of our current system of handwritten prescriptions,” says Stephen Klasko, MD, MBA, Chief Executive Officer of USF Health and Dean of the University of South Florida College of Medicine, in an announcement.
The SureScripts network connects prescribers in all 50 states to over 50,000 independent and chain pharmacies and the nation's leading payers, providing secure electronic access to prescription benefit and history information and the ability to route prescriptions electronically.
“In the past two years, the U.S. has gone from 19,000 to 103,000 prescribers routing prescriptions electronically, punctuated by 39% sequential growth in prescriber adoption in the first quarter of this year,” says Harry Totonis, president and CEO of SureScripts, in an announcement. “The past two years have also witnessed a sevenfold increase in the use of e-prescribing. And while this growth shows clear evidence that the steps taken by policymakers, prescribers, payers, pharmacies, and others are having a positive impact, swift and specific action is required for the U.S. to achieve mainstream adoption and use of e-prescribing.”
The nationwide effort to replace paper prescriptions with e-prescribing is far from over, says SureScripts: despite the growth, only about 10% of eligible prescriptions are now routed electronically.
LogiPharma Unpacked: Highlights, Key Insights, and the Road to 2025
October 16th 2024In this special post-show episode, we sit down with Ryan Portela, Head of Production for LogiPharma, to reflect on the highlights and key takeaways from this year’s event. From attendee feedback to the most impactful sessions, Ryan shares insider insights and discusses how the momentum from 2024 will continue to shape the future of pharma supply chains. Plus, get a sneak peek into the exciting plans for LogiPharma's 20th Anniversary in 2025.
Reimagining Closed-Loop Marketing Strategies for Pharma Companies
November 21st 2024The pharmaceutical industry is evolving, and so are the strategies needed to connect with healthcare professionals. Closed-loop marketing (CLM) has become essential in delivering personalized, data-driven engagement that resonates with physicians and improves key outcomes, such as enhancing patient care, increasing
Maximize Pharma’s Potential with AI-Ready Data for Commercial Excellence
November 21st 2024As the pharmaceutical industry embraces the power of AI, having data that’s large, diverse, and well-structured is critical for driving innovation and improving outcomes. Ensuring your data is AI-ready and can be used with more advanced solutions enables your teams to make informed strategic decisions, predict trends, enhance customer engagements and drive overall strategy.